Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

S&EBio Co. Ltd.

Clinical trials sponsored by S&EBio Co. Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy particles aim to boost stroke recovery Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Gene therapy particles aim to boost stroke recovery

Disease control Recruiting now

This early-stage trial tests a new drug called SNE-101 in people who have had an acute ischemic stroke within the past five days. The main goal is to see if SNE-101 is safe and tolerable, and to find the highest safe dose. The study also looks at whether SNE-101 can improve motor…

Phase 1 • Sponsor: S&Ebio Co. Ltd. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC